These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15496165)

  • 1. Real-time observation of glomerular hemodynamic changes in diabetic rats: effects of insulin and ARB.
    Li B; Yao J; Kawamura K; Oyanagi-Tanaka Y; Hoshiyama M; Morioka T; Gejyo F; Uchiyama M; Oite T
    Kidney Int; 2004 Nov; 66(5):1939-48. PubMed ID: 15496165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
    Onozato ML; Tojo A; Goto A; Fujita T; Wilcox CS
    Kidney Int; 2002 Jan; 61(1):186-94. PubMed ID: 11786100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy.
    Sugimoto H; Shikata K; Matsuda M; Kushiro M; Hayashi Y; Hiragushi K; Wada J; Makino H
    Diabetologia; 1998 Dec; 41(12):1426-34. PubMed ID: 9867209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo visualization of glomerular microcirculation and hyperfiltration in streptozotocin-induced diabetic rats.
    Satoh M; Kobayashi S; Kuwabara A; Tomita N; Sasaki T; Kashihara N
    Microcirculation; 2010 Feb; 17(2):103-12. PubMed ID: 20163537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in renal vessels following the long-term administration of an angiotensin II receptor blocker in Zucker fatty rats.
    Nakanishi K; Nagai Y; Honglan Piao ; Akimoto T; Kato H; Yanakieva-Georgieva N; Ishikawa Y; Yoshihara K; Ito K; Yamanaka N; Oite T
    J Renin Angiotensin Aldosterone Syst; 2011 Jun; 12(2):65-74. PubMed ID: 21385769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
    Bennai F; Morsing P; Paliege A; Ketteler M; Mayer B; Tapp R; Bachmann S
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S104-15. PubMed ID: 9892150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy.
    Satoh M; Fujimoto S; Arakawa S; Yada T; Namikoshi T; Haruna Y; Horike H; Sasaki T; Kashihara N
    Nephrol Dial Transplant; 2008 Dec; 23(12):3806-13. PubMed ID: 18596126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.
    Hiragushi K; Wada J; Eguchi J; Matsuoka T; Yasuhara A; Hashimoto I; Yamashita T; Hida K; Nakamura Y; Shikata K; Minamino N; Kangawa K; Makino H
    Kidney Int; 2004 Feb; 65(2):540-50. PubMed ID: 14717924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time observation of hemodynamic changes in glomerular aneurysms induced by anti-Thy-1 antibody.
    Oyanagi-Tanaka Y; Yao J; Wada Y; Morioka T; Suzuki Y; Gejyo F; Arakawa M; Oite T
    Kidney Int; 2001 Jan; 59(1):252-9. PubMed ID: 11135078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan improves endothelial dysfunction and renal autoregulation in Dahl salt-sensitive rats.
    Satoh M; Haruna Y; Fujimoto S; Sasaki T; Kashihara N
    Hypertens Res; 2010 Feb; 33(2):135-42. PubMed ID: 19927153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide.
    De Vriese AS; Stoenoiu MS; Elger M; Devuyst O; Vanholder R; Kriz W; Lameire NH
    Kidney Int; 2001 Jul; 60(1):202-10. PubMed ID: 11422752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats.
    Kamikawa A; Ishii T; Shimada K; Makondo K; Inanami O; Sakane N; Yoshida T; Saito M; Kimura K
    Diabetes Metab Res Rev; 2008; 24(4):331-8. PubMed ID: 18088079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats.
    Yamashita T; Shikata K; Matsuda M; Okada S; Ogawa D; Sugimoto H; Wada J; Makino H
    Diabetes Res Clin Pract; 2002 Sep; 57(3):149-61. PubMed ID: 12126764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCV 116 prevents progressive renal injury in rats with extensive renal mass ablation.
    Mackenzie HS; Troy JL; Rennke HG; Brenner BM
    J Hypertens Suppl; 1994 Nov; 12(9):S11-6. PubMed ID: 7884578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
    Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
    Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis.
    Mahmood J; Khan F; Okada S; Kumagai N; Morioka T; Oite T
    Kidney Int; 2006 Nov; 70(9):1591-8. PubMed ID: 16985512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
    Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
    Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats].
    Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ
    Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
    Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
    J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.